1 / 15

North America Wound Debridement Products Market Analysis | Coherent Market Insights

Read here the market research report on u201cNorth America Wound Debridement Products Marketu201d published by CMI team.

Download Presentation

North America Wound Debridement Products Market Analysis | Coherent Market Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Coherent Market InsightS Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. North America Wound Debridement Products Market Analysis (2020-2027) • Wound debridement is the process of removing dead tissue from wounds. Biological debridement, enzymatic debridement, autolytic debridement, and mechanical debridement are some of the types of wound debridement. Hydrotherapy, wet-to-dry dressing, and monofilament debridement pads are the types of mechanical debridement. • North America wound debridement products market is estimated to account for US$ 223.4 Mn in terms of value in 2019 and is expected to reach US$ 378.3 Mn by the end of 2027.

  3. North America Wound Debridement Products Market: Drivers • Increasing cases of injuries/ trauma are expected to propel growth of North America wound debridement products market. For instance, according to January 2018 factsheet of the World Health Organization, 20–30% of older people who fall suffer moderate to severe injuries such as bruises, hip fractures, or head trauma, in the U.S. • Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, geriatric population in the U.S. is expected to reach 77 million by 2035. • U.S. held dominant position in North America wound debridement products market in 2018, accounting for 88.1% share in terms of value, followed by Canada.

  4. North America Wound Debridement Products Market: Restraints • Surgical debridement and mechanical debridement have a higher risk for bleeding and peri-procedural pain, which limits their adoption, thereby hindering growth of the market.   • Moreover, lack of standard usage guidelines and trained manpower is also expected to limit growth of the market.  Usage of devices such as hydrosurgical debridement devices, low frequency ultrasound, and surgical wound debridement lack standard guidelines and usage indications for various disorders. There is also lack of trained professionals to guide patients in the usage of these devices for different conditions in the long-term treatment plan.

  5. North America Wound Debridement Products Market: Opportunities  • Market players need to develop and introduce affordable sophisticated systems with easy-to-operate features to boost adoption of wound debridement products in homecare settings. • Moreover, improved reimbursement rates for wound debridement products is also expected aid in growth of the market. Wound debridement products used at home are covered under Medicare Part – B.

  6. s • Chronic ulcers segment in North America wound debridement products market was valued at US$ 88.4 Mn in 2018 and is expected to reach US$ 175.1 Mn by 2027 at a CAGR of 8.2% during the forecast period.

  7. Market Trends/Key Takeaways • American Society of Plastic Surgeons (ASPS) emphasizes on debridement in case of severe infections. Physicians in the U.S. recommend the use of appropriate and safe forms of debridement where the autolytic is safe. The demand of small debridement equipment such as scalpel and enzymatic solutions is also high in the market. • Increasing prevalence of diabetes in the U.S is leading to high demand for wound debridement products. For instance, according to International Diabetes Federation’s IDF Diabetes Atlas 2019 Edition, the numbers of adults with diabetes in the U.S. was 31.0 million.

  8. Regulations • U.S. • Delegation of Duties • The term “wound debridement” as used in section 12-41-113(3), C.R.S., refers to sharp, enzymatic, selective, and pharmacological wound debridement and can only be performed by a licensed physical therapist unless otherwise authorized by Colorado law. A physical therapist may not delegate such wound debridement to unlicensed personnel, but may delegate soft or nonselective wound debridement to a physical therapist assistant. • Supervision of Physical Therapist Assistants • the physical therapist may supervise the physical therapist assistant performing all acts that are included in the practice of physical therapy as defined in § 12-41-103(6), C.R.S., except for the therapies and procedures identified in Rule 1(D) above or acts that are otherwise prohibited by law. Physical therapist assistants may perform soft or non-selective wound debridement as noted in Rule 1(E), but may not perform sharp, enzymatic, selective, and pharmacological wound debridement

  9. Value Chain Analysis

  10. North America Wound Debridement Products Market: Competitive Landscape • Major players operating in North America wound debridement products market include, Smith & Nephew plc, Zimmer Biomet, DeRoyal Industries, Inc., Lohmann & Rauscher International, Arobella Medical, LLC, Bactiguard AB, MediWound Ltd., Misonix, Inc., Söring GmbH, BSN Medical, and Derma Sciences Inc.

  11. North America Wound Debridement Products Market: Key Developments • Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in March 2020, Bactiguard AB acquired Vigilenz Medical Devices and Vigilenz Medical Supplies. • Major players in the market are also focused on conducting clinical trials to expand their product portfolio. For instance, in December 2019, MediWound Ltd. initiated Phase 2 clinical study of EscharEx, a topical biologic drug candidate designed to enzymatically debride chronic wounds, for the treatment of venous leg ulcers.

  12. Request sample copy here • Request PDF brochure here • Request Customization here • Talk to Analyst • Buy Now • Reference: • https://www.coherentmarketinsights.com/market-insight/north-america-wound-debridement-products-market-3665

  13. About Us: • Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. • What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  14. Contact Us: • Mr. Shah • Coherent Market Insights Pvt. Ltd. • Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S. • Phone: +1-206-701-6702 • Email :sales@coherentmarketinsights.com

  15. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related